
    
      To evaluate whether albumin administration after an episode of hepatic encephalopathy (â‰¥
      grade II) improves survival at 30, 90 and 180 days.

        -  to evaluate the effects of albumin on hepatic encephalopathy recurrence during the study
           period.

        -  To analyze whether albumin administration reduces hospitalization requirement.

        -  To study the effects of albumin on circulatory dysfunction index (mean arterial
           pressure, renal function, plasma vasopressor hormones).
    
  